[1]
|
Tysnes, O.-B. and Storstein, A. (2017) Epidemiology of Parkinson’s Disease. Journal of Neural Transmission, 124, 901-905. https://doi.org/10.1007/s00702-017-1686-y
|
[2]
|
Li, G., Ma, J., Cui, S., He, Y., Xiao, Q., Liu, J. and Chen, S. (2019) Parkinson’s Disease in China: A Forty-Year Growing Track of Bedside Work. Translational Neuro-degeneration, 8, Article No. 22.
https://doi.org/10.1186/s40035-019-0162-z
|
[3]
|
Li, T. and Le, W. (2020) Biomarkers for Parkinson’s Disease: How Good Are They? Neuroscience Bulletin, 36, 183-194. https://doi.org/10.1007/s12264-019-00433-1
|
[4]
|
Tenhunen, R., Marver, H.S. and Schmid, R. (1969) Microsomal Heme Oxygenase. Journal of Biological Chemistry, 244, 6388-6394. https://doi.org/10.1016/S0021-9258(18)63477-5
|
[5]
|
Wu, Y.H. and Hsieh, H.L. (2022) Roles of Heme Oxygen-ase-1 in Neuroinflammation and Brain Disorders. Antioxidants (Basel), 11, Article No. 923. https://doi.org/10.3390/antiox11050923
|
[6]
|
Ryter, S.W. and Choi, A.M. (2016) Targeting Heme Oxygenase-1 and Carbon Monoxide for Therapeutic Modulation of Inflammation. Translational Research, 167, 7-34. https://doi.org/10.1016/j.trsl.2015.06.011
|
[7]
|
Feng, C.W., Hung, H.C., Huang, S.Y., Chen, C.H., Chen, Y.R., Chen, C.Y., Yang, S.N., Wang, H.D., Sung, P.J., Sheu, J.H., Tsui, K.H., Chen, W.F. and Wen, Z.H. (2016) Neuropro-tective Effect of the Marine-Derived Compound 11-Dehydrosinulariolide through DJ-1-Related Pathway in in Vitro and in Vivo Models of Parkinson’s Disease. Marine Drugs, 14, Article No. 187. https://doi.org/10.3390/md14100187
|
[8]
|
Fernandez-Fierro, A., Funes, S.C., Rios, M., Covian, C., Gonzalez, J. and Kalergis, A.M. (2020) Immune Modulation by Inhibitors of the HO System. International Journal of Molecular Sciences, 22, Article No. 294.
https://doi.org/10.3390/ijms22010294
|
[9]
|
Cressatti, M., Song, W., Turk, A.Z., Garabed, L.R., Benchaya, J.A., Galindez, C., Liberman, A. and Schipper, H.M. (2019) Glial HMOX1 Expression Promotes Central and Peripheral Al-pha-Synuclein Dysregulation and Pathogenicity in Parkinsonian Mice. Glia, 67, 1730-1744. https://doi.org/10.1002/glia.23645
|
[10]
|
Sun, W., Zheng, J., Ma, J., Wang, Z., Shi, X., Li, M., Huang, S., Hu, S., Zhao, Z. and Li, D. (2021) Increased Plasma Heme Oxygenase-1 Levels in Patients with Early-Stage Parkinson’s Dis-ease. Frontiers in Aging Neuroscience, 13, Article ID: 621508. https://doi.org/10.3389/fnagi.2021.621508
|
[11]
|
Schipper, H.M. and Song, W. (2015) A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders. International Journal of Molecular Sciences, 16, 5400-5419. https://doi.org/10.3390/ijms16035400
|
[12]
|
Fahn, S. and Cohen, G. (1992) The Oxidant Stress Hy-pothesis in Parkinson’s Disease: Evidence Supporting It. Annals of Neurology, 32, 804-812. https://doi.org/10.1002/ana.410320616
|
[13]
|
Gaki, G.S. and Papavassiliou, A.G. (2014) Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease. NeuroMolecular Medicine, 16, 217-230. https://doi.org/10.1007/s12017-014-8294-x
|
[14]
|
Wang, Y., Gao, L., Chen, J., Li, Q., Huo, L., Wang, Y., Wang, H. and Du, J. (2021) Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease. Frontiers in Pharmacology, 12, Article ID: 757161. https://doi.org/10.3389/fphar.2021.757161
|
[15]
|
Lushchak, V.I. and Storey, K.B. (2021) Oxidative Stress Concept Updated: Definitions, Classifications, and Regulatory Pathways Implicated. EXCLI Journal, 20, 956-967.
|
[16]
|
Dong, H., Zhang, J., Rong, H., Zhang, X. and Dong, M. (2021) Paeoniflorin and Plycyrrhetinic Acid Synergistically Alleviate MPP(+)/MPTP-Induced Oxidative Stress through Nrf2-Dependent Glutathione Biosynthesis Mechanisms. ACS Chemi-cal Neuroscience, 12, 1100-1111. https://doi.org/10.1021/acschemneuro.0c00544
|
[17]
|
Zawada, W.M., Banninger, G.P., Thornton, J., Marriott, B., Cantu, D., Rachubinski, A.L., Das, M., Griffin, W.S. and Jones, S.M. (2011) Genera-tion of Reactive Oxygen Species in 1-Methyl-4-Phenylpyridinium (MPP+) Treated Dopaminergic Neurons Occurs as an NADPH Oxidase-Dependent Two-Wave Cascade. Journal of Neuroinflammation, 8, Article No. 129. https://doi.org/10.1186/1742-2094-8-129
|
[18]
|
Sharma, N., Khurana, N., Muthuraman, A. and Utreja, P. (2021) Pharmacological Evaluation of Vanillic Acid in Rotenone-Induced Parkinson’s Disease Rat Model. European Journal of Pharmacology, 903, Article ID: 174112.
https://doi.org/10.1016/j.ejphar.2021.174112
|
[19]
|
Zou, Z.C., Fu, J.J., Dang, Y.Y., Zhang, Q., Wang, X.F., Chen, H.B., Jia, X.J., Lee, S.M. and Li, C.W. (2021) Pinocembrin-7-Methylether Protects SH-SY5Y Cells against 6-Hydroxydopamine-Induced Neurotoxicity via Modulating Nrf2 Induction through AKT and ERK Pathways. Neuro-toxicity Research, 39, 1323-1337.
https://doi.org/10.1007/s12640-021-00376-4
|
[20]
|
Bae, J.W., Kim, M.J., Jang, C.G. and Lee, S.Y. (2010) Protec-tive Effects of Heme Oxygenase-1 against MPP(+)-Induced Cytotoxicity in PC-12 Cells. Neurological Sciences, 31, 307-313.
https://doi.org/10.1007/s10072-010-0216-6
|
[21]
|
Jin, X., Liu, Q., Jia, L., Li, M. and Wang, X. (2015) Pinocembrin Attenuates 6-OHDA-Induced Neuronal Cell Death through Nrf2/ARE Pathway in SH-SY5Y Cells. Cellular and Molec-ular Neurobiology, 35, 323-333.
https://doi.org/10.1007/s10571-014-0128-8
|
[22]
|
Youn, J.K., Kim, D.W., Kim, S.T., Park, S.Y., Yeo, E.J., Choi, Y.J., Lee, H.R., Kim, D.S., Cho, S.W., Han, K.H., Park, J., Eum, W.S., Hwang, H.S. and Choi, S.Y. (2014) PEP-1-HO-1 Prevents MPTP-Induced Degeneration of Dopaminergic Neurons in a Parkinson’s Disease Mouse Model. BMB Reports, 47, 569-574.
https://doi.org/10.5483/BMBRep.2014.47.10.286
|
[23]
|
Li, S.J., Ren, Y.D., Li, J., Cao, B., Ma, C., Qin, S.S. and Li, X.R. (2020) The Role of Iron in Parkinson’s Disease Monkeys Assessed by Susceptibility Weighted Imaging and Induc-tively Coupled Plasma Mass Spectrometry. Life Sciences, 240, Article ID: 117091. https://doi.org/10.1016/j.lfs.2019.117091
|
[24]
|
Huo, T., Jia, Y., Yin, C., Luo, X., Zhao, J., Wang, Z. and Lv, P. (2019) Iron Dysregulation in Vascular Dementia: Focused on the AMPK/Autophagy Pathway. Brain Research Bulletin, 153, 305-313.
https://doi.org/10.1016/j.brainresbull.2019.09.006
|
[25]
|
Langley, J., He, N., Huddleston, D. E., Chen, S., Yan, F., Crosson, B., Factor, S. and Hu, X. (2019) Reproducible Detection of Nigral Iron Deposition in 2 Parkinson’s Disease Cohorts. Movement Disorders, 34, 416-419.
https://doi.org/10.1002/mds.27608
|
[26]
|
Mahoney-Sanchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J.A. and Devedjian, J.C. (2021) Ferroptosis and Its Potential Role in the Physiopathology of Parkinson’s Disease. Progress in Neurobiology, 196, Article ID: 101890.
https://doi.org/10.1016/j.pneurobio.2020.101890
|
[27]
|
Masaldan, S., Bush, A.I., Devos, D., Rolland, A.S. and Moreau, C., (2019) Striking While the Iron Is Hot: Iron Metabolism and Ferroptosis in Neurodegeneration. Free Radical Biology and Medicine, 133, 221-233.
https://doi.org/10.1016/j.freeradbiomed.2018.09.033
|
[28]
|
Mochizuki, H., Choong, C.J. and Baba, K. (2020) Par-kinson’s Disease and Iron. Journal of Neural Transmission (Vienna), 127, 181-187. https://doi.org/10.1007/s00702-020-02149-3
|
[29]
|
Choi, Y.K. and Kim, Y.-M. (2022) Beneficial and Detrimental Roles of Heme Oxygenase-1 in the Neurovascular System. International Journal of Molecular Sciences, 23, Article No. 7041. https://doi.org/10.3390/ijms23137041
|
[30]
|
Chen, J. (2014) Heme Oxygenase in Neuroprotection: From Mechanisms to Therapeutic Implications. Reviews in the Neurosciences, 25, 269-280. https://doi.org/10.1515/revneuro-2013-0046
|
[31]
|
Consoli, V., Sorrenti, V., Grosso, S. and Vanella, L. (2021) Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions. Biomolecules, 11, Article No. 589. https://doi.org/10.3390/biom11040589
|
[32]
|
Figura, M. and Friedman, A. (2020) In Search of Parkinson’s Disease Biomarkers—Is the Answer in Our Mouths? A Systematic Review of the Literature on Salivary Biomarkers of Parkinson’s Disease. Neurologia i Neurochirurgia Polska, 54, 14-20. https://doi.org/10.5603/PJNNS.a2020.0011
|
[33]
|
Inose, Y., Izumi, Y., Takada-Takatori, Y., Akaike, A., Koyama, Y., Kaneko, S. and Kume, T. (2020) Protective Effects of Nrf2-ARE Activator on Dopaminergic Neuronal Loss in Par-kinson Disease Model Mice: Possible Involvement of Heme Oxygenase-1. Neuroscience Letters, 736, Article ID: 135268. https://doi.org/10.1016/j.neulet.2020.135268
|
[34]
|
Waza, A. A., Hamid, Z., Ali, S., Bhat, S.A. and Bhat, M.A. (2018) A Review on Heme Oxygenase-1 Induction: Is It a Necessary Evil. Inflammation Research, 67, 579-588. https://doi.org/10.1007/s00011-018-1151-x
|
[35]
|
Masaki, Y., Izumi, Y., Matsumura, A., Akaike, A. and Kume, T. (2017) Protective Effect of Nrf2-ARE Activator Isolated from Green Perilla Leaves on Dopaminergic Neuronal Loss in a Parkinson’s Disease Model. European Journal of Pharmacology, 798, 26-34. https://doi.org/10.1016/j.ejphar.2017.02.005
|
[36]
|
Hung, S.Y., Liou, H.C. and Fu, W.M. (2010) The Mechanism of Heme Oxygenase-1 Action Involved in the Enhancement of Neurotrophic Factor Expression. Neuropharmacology, 58, 321-329.
https://doi.org/10.1016/j.neuropharm.2009.11.003
|
[37]
|
Song, W., Patel, A., Qureshi, H.Y., Han, D., Schipper, H.M. and Paudel, H.K. (2009) The Parkinson Disease-Associated A30P Mutation Stabilizes Alpha-Synuclein against Proteasomal Degradation Triggered by Heme Oxygenase-1 Over-Expression in Human Neuroblastoma Cells. Journal of Neurochemistry, 110, 719-733.
https://doi.org/10.1111/j.1471-4159.2009.06165.x
|
[38]
|
Tong, H., Zhang, X., Meng, X., Lu, L., Mai, D. and Qu, S. (2018) Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxi-dant Protein in Parkinson Disease Models. Frontiers in Molecular Neuroscience, 11, Article No. 165. https://doi.org/10.3389/fnmol.2018.00165
|